sar
particularli
effici
ensur
entir
countri
brought
standstil
repercuss
rang
rampant
mortal
fear
paranoia
econom
recess
viru
brought
togeth
countri
order
look
possibl
therapeut
countermeasur
prophylact
intervent
possibl
month
away
particularli
effect
slew
measur
possibl
concern
design
vaccin
work
upon
attempt
structur
base
approach
util
combin
epitop
predict
server
develop
multiepitop
base
subunit
vaccin
involv
two
major
domain
spike
glycoprotein
sar
coupl
substanti
effect
chimer
adjuv
act
triagonist
substanti
creat
stabl
vaccin
construct
md
simul
design
construct
evalu
base
dock
toll
like
receptor
tlr
find
provid
epitopebas
peptid
fragment
potenti
candid
develop
vaccin
interact
human
made
publicli
avail
rcsb
pdb
allow
commun
proceed
toward
develop
probabl
therapeut
measur
rang
repurpos
drug
design
small
molecul
inhibitor
identif
uniqu
target
elucid
molecular
mechan
viral
protein
machineri
establish
insid
host
bodi
interact
spike
glycoprotein
human
receptor
import
initi
process
viral
entri
human
be
contact
infect
individu
identif
probabl
site
upstream
receptor
bind
motif
includ
residu
interact
undergo
cleavag
requir
prime
stabl
fusion
viral
membran
complex
involv
suffici
nonrevers
conform
chang
put
motion
process
viral
entri
vaccin
peg
effect
measur
posit
singlestrand
rna
viru
sever
alreadi
underway
sinc
regard
suitabl
measur
immun
individu
world
stop
diseas
steamrol
countri
paper
investig
util
spike
glycoprotein
sar
probabl
immunogen
design
multiepitop
peptid
base
subunit
vaccin
chimer
adjuv
tow
spike
glycoprotein
evidenc
appropri
immunogen
capabl
elicit
neutral
antibodi
inadvert
lead
establish
elicit
immun
respons
prevent
viral
entri
act
prophylact
work
envisag
predict
signific
epitop
design
multiepitop
base
peptid
subunit
vaccin
coupl
chimer
adjuv
immunogen
consid
involv
two
domain
spike
glycoprotein
involv
bind
follow
viral
cellular
membran
fusion
respect
cleavag
site
present
postfus
consid
due
previou
apprehens
hypersensit
immun
system
consid
entir
spike
glycoprotein
sarscov
util
epitop
vaccin
construct
across
experiment
set
help
provid
essenti
evalu
aid
develop
vaccin
gener
robust
immunolog
prophylact
respons
spike
glycoprotein
sequenc
pdb
id
check
specif
domain
identifi
domain
residu
compris
receptor
bind
domain
rbd
along
domain
residu
edit
cryoem
structur
surfac
glycoprotein
use
ucsf
chimera
base
sequenc
domain
separ
use
predict
linear
epitop
capabl
elicit
b
cell
differ
server
artifici
neural
network
ann
base
approach
server
abcpr
bcepr
immun
epitop
databas
analysi
resourc
iedb
base
linear
b
cell
epitop
predict
tool
util
predict
probabl
epitop
sequenc
across
queri
sequenc
latter
two
server
util
physicochem
paramet
like
hydrophil
polar
surfac
access
flexibl
predict
b
cell
epitop
previous
evidenc
predict
linear
b
cell
sequenc
abcpr
match
probabl
epitop
predict
differ
paramet
inclus
surfac
access
area
hydrophil
polar
flexibl
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
order
two
server
bepipr
base
linear
predict
epitop
corrobor
paramet
paramet
check
predict
epitop
bcepr
predict
epitop
basi
paramet
consensu
sequenc
emerg
consid
probabl
epitop
regard
sinc
conform
discontinu
b
cell
epitop
could
predict
ellipro
discotop
util
analysi
consensu
sequenc
arriv
upon
earlier
consensu
epitop
predict
server
probabl
mhc
ii
bind
epitop
domain
predict
consensu
approach
util
arriv
conclus
sequenc
predict
helper
lymphocyt
made
mhcpred
syfpeithi
netmhciipan
server
iedb
server
consensu
select
epitop
four
differ
server
allow
us
improv
upon
circumv
limit
associ
predict
mhc
ii
binder
due
polymorph
natur
peptid
length
variat
also
determin
appropri
peptid
bind
core
henc
base
carri
compar
studi
util
experiment
valid
dataset
server
determin
among
best
avail
util
avenu
syfpeithi
predict
nonam
sequenc
base
weight
contribut
amino
acid
sequenc
present
across
predict
epitop
sequenc
mhcpred
allow
predict
epitop
base
multivari
statist
method
netmhciipan
allow
determin
epitop
fragment
limit
allel
specif
choic
iedb
base
mhc
ii
bind
epitop
sequenc
predict
server
also
util
sinc
employ
combin
method
rang
ann
smm
rank
probabl
epitop
basi
percentil
score
ic
scoreth
sequenc
predict
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
differ
server
either
mer
mer
base
server
use
base
consensu
select
across
platform
uniform
epitop
select
predict
cytotox
lymphocyt
cell
ctl
mhc
bind
server
involv
util
netmhc
mhcnp
netctl
iedb
base
cell
epitop
tool
predict
server
predict
nonam
epitop
sequenc
util
default
dataset
identifi
literatur
probabl
interact
human
leukocyt
antigen
allel
sar
cov
employ
consensu
select
predict
four
server
abl
list
appropri
ctl
epitop
rel
confid
netmhc
util
artifici
neural
network
predict
epitop
netctl
server
allow
identif
epitop
base
improv
dataset
sensit
specif
across
filter
threshold
employ
mhcnp
employ
machin
learn
approach
toward
predict
natur
process
epitop
mhc
wherea
iedb
base
mhc
base
predict
cell
epitop
sort
epitop
base
percentil
score
low
ic
valu
across
combin
ann
smm
approach
base
appropri
peptid
librari
mhc
allel
specif
sar
cov
manifest
base
allel
confirm
outbreak
sar
cov
begin
millennium
consensu
thu
arriv
upon
suitabl
consid
probabl
sequenc
capabl
elicit
necessari
immun
respons
apart
sequenc
filter
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
base
predict
antigen
vaxijen
allergen
allertop
algpr
toxic
toxinpr
capabl
elicit
interferongamma
ifng
along
epitop
sequenc
match
human
protein
prevent
case
antibodi
respons
selfantigen
multipl
peptid
match
tool
epitop
sequenc
match
correspond
secondari
structur
cryoem
structur
pdb
id
list
either
alpha
helic
coil
strand
beta
sheet
done
allow
sequenc
arrang
allow
improv
molecular
model
anoth
thing
consid
initi
base
conserv
surfac
glycoprotein
across
differ
strain
deposit
gisaid
repositori
http
wwwgisaidorgaboutusmiss
opinion
much
variabl
observ
across
strain
led
us
check
coverag
epitop
sequenc
predict
sequenc
repositori
surfac
glycoprotein
also
genom
sequenc
deposit
ncbi
india
peptid
base
subunit
vaccin
predict
b
cell
epitop
suffici
elicit
strong
immun
respons
gener
prophylact
measur
necessari
therefor
suitabl
adjuv
must
also
ad
vaccin
design
case
purif
carri
separ
purif
adjuv
peptid
epitop
sequenc
separ
recent
sever
approach
made
util
chimer
adjuv
compris
two
separ
identifi
adjuv
similar
approach
carri
silico
design
compris
three
differ
adjuv
evid
use
adjuv
differ
vaccin
agonist
receptor
util
recent
review
suitabl
adjuv
differ
tlr
util
approach
back
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
experiment
evid
identifi
adjuv
capabl
elicit
immun
respons
interact
toll
like
receptor
tlr
separ
downstream
immun
signal
gener
necessari
prophylact
measur
expect
vaccin
sar
gener
neutral
antibodi
peptid
sequenc
surfac
glycoprotein
alreadi
evidenc
previou
instanc
henc
link
triagonist
chimer
adjuv
would
help
util
suitabl
prophylact
measur
suitabl
rigid
linker
util
join
peptid
sequenc
posit
rearrang
ntermin
design
sever
construct
vaccin
singl
construct
adjuv
n
c
termin
vaccin
also
design
appropri
appropri
linker
util
join
intra
b
cell
epitop
helper
cytotox
epitop
also
construct
design
compris
b
cell
epitop
link
adjuv
rigid
eaaak
linker
helix
form
toward
n
termin
follow
gpgpg
linker
link
htl
epitop
aay
linker
ctl
epitop
toward
c
termin
xp
n
linker
util
link
three
adjuv
n
termin
three
adjuv
rearrang
time
n
termin
determin
construct
lead
us
stabl
construct
molecular
model
subsequ
dock
vaccin
construct
analyz
physicochem
properti
use
protparam
tool
allergen
antigen
scan
probabl
stimul
interferon
gamma
toxinpr
databas
use
analyz
unit
vaccin
construct
henc
construct
consid
nontox
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
main
challeng
associ
molecular
model
vaccin
construct
adjuv
specif
region
epitop
specif
region
match
two
differ
templat
although
case
suffici
sequenc
coverag
call
homolog
model
vaccin
construct
multitempl
align
turn
bust
sinc
model
structur
obtain
compris
entir
strand
would
made
model
construct
unstabl
anoth
approach
took
model
two
part
vaccin
construct
separ
use
singl
templat
link
loop
energi
minim
construct
fell
robetta
server
allow
compar
model
howev
brought
promis
model
vaccin
construct
suffici
secondari
structur
coverag
construct
deposit
galaxi
webserv
refin
base
select
paramet
base
model
construct
refin
best
structur
carri
forward
valid
ramachandran
plot
zscore
procheck
prosaweb
server
addit
valid
carri
use
server
model
vaccin
construct
check
sequenc
mismatch
none
found
construct
assess
stabil
protparam
server
variou
marker
stabil
made
avail
instabl
index
ii
pest
hypothesi
vivo
halflif
isoelectr
point
assess
base
ramachandran
plot
errat
whatcheck
prosaweb
server
allow
us
select
singl
vaccin
construct
prolong
molecular
dynam
simul
determin
stabil
construct
probabl
use
vivo
set
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
md
simul
obtain
elabor
insight
dynam
stabil
construct
physiolog
condit
perform
desmond
e
shaw
research
desr
protein
structur
subject
minim
x
x
period
boundari
box
water
model
use
fast
scalabl
algorithm
util
distribut
memori
parallel
program
counterion
salt
ad
neutral
system
pressur
temperatur
maintain
use
nosehoov
thermostat
martynatobiasklein
barostat
bar
respect
system
run
npt
ensembl
trajectori
analyz
simul
interact
diagram
desmond
vmd
rational
behind
select
pdb
id
fact
case
sar
cov
hiv
influenza
rna
base
virus
tolllik
receptor
experiment
evidenc
implic
bind
site
determin
avail
pdb
id
show
bind
adjuv
lipopolysaccharid
toll
like
receptor
also
ellipro
castp
carri
patchdock
firedock
sequenc
sar
cov
surfac
glycoprotein
retriev
genbank
fasta
format
ucsf
chimera
visual
softwar
util
edit
structur
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
includ
domain
separ
entiti
use
domain
separ
without
includ
cleavag
site
fall
two
domain
figur
develop
immunogen
due
previous
evidenc
case
increas
hypersensit
concern
util
entir
length
spike
glycoprotein
vaccin
immunogen
although
select
epitop
base
multipl
server
sinc
rational
heurist
base
role
differ
algorithm
lead
server
arriv
predict
epitop
base
stringent
filter
appli
case
epitop
predict
differ
server
manual
curat
arriv
consensu
sequenc
case
epitop
sequenc
specif
separ
predict
server
list
case
b
cell
mhc
ii
epitop
mer
epitop
sequenc
gener
case
mhc
epitop
sequenc
nonam
fragment
gener
sequenc
predict
match
data
gener
iedb
signific
epitop
present
surfac
glycoprotein
mention
need
analysi
predict
site
henc
util
stringent
filter
differ
server
follow
valid
util
specif
allel
identifi
previou
manifest
sar
cov
help
us
sort
predict
cell
epitop
appropri
differ
server
otherwis
would
made
predict
bias
select
epitop
list
tabl
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
variou
paramet
select
epitop
adjuv
filter
includ
antigen
allergen
toxic
capabl
gener
interferon
gamma
respons
tabl
b
c
chanc
identifi
selfantigen
human
immun
system
among
epitop
sequenc
henc
filter
percent
sequenc
coverag
detect
singl
residu
mutat
still
denot
percent
ident
residu
consid
vaccin
construct
aberr
gener
isol
domain
regardless
singl
residu
mismatch
spread
vaccin
definit
substanti
effect
act
immunogen
across
clinic
set
differ
countri
henc
sequenc
coverag
base
valid
select
epitop
also
carri
list
epitop
consid
design
vaccin
includ
sequenc
conform
sequenc
coverag
percent
ident
matrix
util
indic
indian
sequenc
show
percent
ident
epitop
util
show
sequenc
coverag
across
sequenc
submit
india
spike
glycoprotein
figur
triagonist
chimer
adjuv
propens
elicit
immun
respons
allow
use
suitabl
adjuv
sar
cov
mtb
base
partial
sequenc
util
endeavor
appropri
rigid
polar
linker
dp
util
regard
among
design
construct
rearrang
valid
base
antigen
score
predict
vaxijen
adjuv
consid
verifi
agonist
use
fragment
mycobacteri
toward
gener
cytokin
natur
killer
cell
verifi
antigen
specif
ctl
respons
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
initi
construct
paramet
across
assess
mention
supplementari
tabl
use
lipopolysaccharid
base
adjuv
abrog
studi
due
constraint
util
model
dock
simul
base
studi
perspect
arrang
valid
antigen
vaccin
construct
base
linker
adjuv
led
termin
select
differ
vaccin
construct
subsequ
character
base
protparam
paramet
determin
molecular
weight
isoelectr
point
predict
stabl
construct
also
construct
found
suitabl
antigen
nontox
nonallergen
region
vaccin
construct
predict
suffici
b
cell
epitop
capabl
gener
interferon
gamma
respons
nearli
sequenc
coverag
tabl
figur
vaccin
construct
thu
design
made
compar
model
robetta
reveal
structur
better
platform
util
regard
figur
valid
refin
model
structur
reveal
stabl
construct
case
promin
detect
predomin
presenc
defin
secondari
structur
across
span
construct
interspers
coil
helic
model
construct
refin
galaxi
server
tabl
valid
ramachandran
plot
zscore
prosawebserv
tabl
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
attempt
made
assess
stabil
design
construct
move
dock
simul
studi
tlr
sinc
compris
three
differ
adjuv
ensembl
differ
sequenc
interspers
across
spike
glycoprotein
becom
imper
construct
evalu
endeavor
util
expasi
protparam
tool
base
assumpt
pest
hypothesi
instabl
index
determin
includ
analysi
residu
make
biomolecul
lower
half
life
increas
instabl
includ
prolin
p
glutam
acid
e
serin
threonin
methionin
glutamin
q
design
construct
includ
guruprasad
basi
rel
abund
asparagin
n
lysin
k
glycin
g
found
stabl
protein
tabl
moreov
basic
neutral
isoelectr
point
also
indic
stabl
vivo
halflif
model
construct
sinc
assess
entir
assumpt
investig
stabil
construct
nanosecond
molecular
dynam
simul
due
constraint
comput
time
effort
assess
stabil
sinc
gave
best
estim
stabil
base
assumpt
list
tabl
b
c
abovement
paramet
went
assumpt
initi
phase
md
simul
major
conform
chang
vaccin
construct
observ
illustr
figur
rest
simul
time
averag
root
mean
squar
deviat
rmsd
calpha
atom
remain
constant
around
figur
suggest
initi
structur
rearrang
vaccin
construct
achiev
stabl
threedimension
structur
evid
supplementari
figur
follow
initi
structur
rearrang
vaccin
construct
achiev
stabl
three
dimension
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
structur
evidenc
superimpos
structur
obtain
ns
ns
figur
follow
anoth
ns
ns
figur
identifi
region
vaccin
construct
contribut
structur
rearrang
root
mean
squar
fluctuat
rmsf
calpha
atom
calcul
ns
anoth
ns
figur
respect
high
residu
fluctuat
due
low
distribut
stabl
secondari
structur
rearrang
region
residu
accompani
abund
loop
observ
rmsf
plot
abund
loop
confer
affinit
abil
complementari
receptor
evalu
secondari
structur
featur
present
vaccin
construct
evalu
dictionari
secondari
structur
plot
dssp
supplementari
figur
simul
indic
conform
stabil
direct
expect
reproduc
experiment
condit
consid
md
may
definit
extrapol
result
includ
construct
suitabl
vaccin
construct
consid
develop
vaccin
sinc
score
similar
index
across
paramet
assess
allow
simul
base
md
simul
observ
shift
model
vaccin
construct
molecular
dock
carri
receptor
vaccin
construct
patchdock
carri
dock
rigid
molecul
base
protocol
employ
molecular
shape
represent
surfac
patch
map
follow
filter
score
obtain
result
refin
rank
use
firedock
base
global
energi
valu
kjmol
help
determin
bind
affin
molecul
consid
result
indic
bind
high
bind
affin
supplementari
tabl
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
global
energi
valu
analog
rank
base
bind
affin
kjmol
interfac
analys
postdock
ucsf
chimera
dimplot
mainli
includ
noncoval
interact
determin
distanc
constraint
two
dock
molecul
involv
hydrogen
bond
hydrophob
interact
across
interfac
residu
specifi
contribut
interact
visual
sphere
depict
basi
correspond
noncoval
interact
across
proteinprotein
interfac
figur
supplementari
figur
dock
conclus
use
assum
bind
vaccin
construct
tlr
receptor
may
elicit
signal
cascad
respons
desir
immun
respons
toward
confer
suitabl
prophylact
effect
util
server
allow
simul
immun
respons
gener
base
vaccin
dosag
util
regard
owe
limit
predict
across
experiment
set
one
potent
option
explor
curtail
spread
includ
design
develop
appropri
vaccin
entir
process
vaccin
develop
involv
extens
timelin
rang
experiment
clinic
set
recent
time
advanc
molecular
immunolog
develop
sever
epitop
map
method
sever
semiempir
approach
vaccin
design
introduc
wherein
multiepitop
peptid
base
subunit
vaccin
base
predict
b
cell
epitop
util
similar
bioinformat
tool
made
remark
stride
despit
con
involv
low
immunogen
multipl
dose
tradeoff
elicit
neutral
antibodi
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
humor
immun
respons
rel
safeti
associ
attenu
inactiv
viru
vaccin
play
favor
approach
look
probabl
limit
strategi
employ
design
epitop
base
peptid
vaccin
util
major
subunit
spike
glycoprotein
select
concern
immunogen
domain
surfac
glycoprotein
util
separ
keep
mind
limit
associ
util
entir
surfac
glycoprotein
predict
three
differ
type
epitop
b
cell
htl
ctl
util
multipl
differ
server
case
base
differ
algorithm
select
base
consensu
involv
server
includ
experiment
basi
behind
allel
hla
class
class
ii
select
help
add
susten
conclud
list
epitop
predict
epitop
verifi
base
describ
paramet
found
antigen
nonallergen
nontox
share
high
coverag
across
spike
glycoprotein
sequenc
base
necess
immunostimul
role
adjuv
becom
import
specif
chimer
adjuv
compris
agonist
design
valid
overlap
b
cell
epitop
region
iedb
server
adjuv
sequenc
experiment
evidenc
gener
neutral
antibodi
cytokin
natur
killer
cell
rigor
assess
implic
toll
like
receptor
case
sar
carri
decid
upon
use
agonist
adjuv
predict
epitop
sequenc
appropri
join
rigid
linker
base
arrang
even
chimer
adjuv
sequenc
link
short
rigid
linker
xp
n
aid
ensur
stabil
gpgpg
aay
linker
use
intra
htl
ctl
linker
respect
separ
vaccin
compon
arriv
upon
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
role
eaaak
linker
adjuv
peptid
epitop
sequenc
design
vaccin
construct
base
arrang
chimer
adjuv
valid
conclud
highli
antigen
nonallergen
nontox
make
limit
subunit
vaccin
mention
stabil
vaccin
construct
assess
base
physicochem
paramet
make
suitabl
purif
across
experiment
set
presenc
cystein
bond
without
introduct
engin
mutat
point
stabil
model
construct
presenc
defin
secondari
structur
characterist
across
model
construct
despit
presenc
mainli
strand
loop
region
induc
intermitt
sequenc
due
predict
epitop
led
us
verifi
stabil
dynam
md
simul
run
moreov
assess
stabil
amino
acid
composit
correl
vivo
halflif
period
calcul
isoelectr
point
help
us
identifi
three
model
five
vaccin
construct
exhibit
similar
stabil
paramet
base
md
simul
construct
extrapol
includ
construct
construct
util
prosa
web
server
save
server
zscore
ramchandran
plot
score
respect
help
valid
model
construct
rigid
base
dock
construct
carri
although
experiment
data
insinu
interact
structur
featur
vaccin
construct
function
characterist
accept
dock
model
achiev
scenario
moreov
n
termin
compos
agonist
help
compound
dock
pose
base
pdb
structur
correspond
bind
site
follow
ellipro
castp
predict
bind
site
receptor
dock
carri
vaccin
construct
patchdock
server
top
pose
base
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
md
simul
dock
pose
definit
timespan
carri
comput
constraint
moreov
becom
imper
sinc
experiment
data
evidenc
verifi
dock
vaccin
construct
actual
determin
proteinprotein
interact
may
carri
run
extens
md
simul
involv
protein
determin
associ
dissoci
profil
alongsid
resid
time
assess
best
dock
pose
two
protein
energi
minim
condit
circumv
limit
associ
unavail
experiment
evid
certain
extent
therefor
studi
includ
md
simul
dock
pose
sinc
would
made
result
bias
albeit
conform
necessari
dock
result
help
us
conclud
work
success
increas
limit
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
b
repres
apart
four
epitop
select
sequenc
coverag
across
submit
indian
sequenc
sar
overal
sequenc
similar
submit
indian
sequenc
across
sequenc
gisaid
indic
overal
coverag
sequenc
epitop
select
vaccin
design
fall
within
accept
paramet
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
figur
calpha
rmsd
vaccin
md
simul
b
rmsf
plot
compris
calpha
atom
base
vaccin
ns
c
rmsf
plot
compris
calpha
atom
base
vaccin
ns
peak
repres
region
loop
abund
base
residu
sequenc
across
residu
index
initi
rearrang
depict
superimpos
frame
vaccin
ns
orang
ns
cyan
e
rearrang
superimpos
frame
ns
yellow
ns
red
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
figur
interfac
vaccin
construct
chain
b
blue
chain
red
mark
residu
involv
across
proteinprotein
interfac
ucsf
chimera
residu
mark
cyan
color
sphere
residu
receptor
dark
green
color
sphere
residu
vaccin
construct
b
residu
across
interfac
label
correspond
interact
take
part
across
interfac
interact
residu
label
supplementari
figur
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
